$AVLN
Avalyn Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$31.52
▼-5.71%-$1.91
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAvalyn Pharma Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is AVLN down today? It is at $31.52 (-5.71%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AVLN spikes, and full due diligence on AVLN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AVLN 11 times in the last 30 days. Create a free account to track $AVLN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AVLN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AVLN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Wellington Biomedical Innovation Master Investors (Cayman) I Beneficial Owner (10%) | Acquired (grant/award) | +1.28M 2.9% of company | n/a | 1.28M | n/a | May 1, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Acquired (grant/award) | +2.75M 6.2% of company | n/a | 1.91M | n/a | May 1, 26 |
Sr One Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +556K 1.3% of company | added 20% | 3.31M | $10.0M at $18.00 | May 1, 26 |
Carroll Jill Director | Acquired (grant/award) | +1.91M 4.3% of company | n/a | 1.91M | n/a | May 1, 26 |
Carroll Jill Director | Bought (open market) | +278K 0.6% of company | added 15% | 2.19M | $5.0M at $18.00 | May 1, 26 |
Fmr Llc Beneficial Owner (10%) | Acquired (grant/award) | +2.28M 5.2% of company | n/a | 2.28M | n/a | May 1, 26 |
Novo Holdings A/S Beneficial Owner (10%) | Acquired (grant/award) | +3.33M 7.5% of company | n/a | 3.33M | n/a | May 1, 26 |
Novo Holdings A/S Beneficial Owner (10%) | Bought (open market) | +556K 1.3% of company | added 17% | 3.88M | $10.0M at $18.00 | May 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AVLN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AVLN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AVLN last traded at $31.52, down 5.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Avalyn Pharma Inc. Common Stock (AVLN) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AVLN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AVLN 11 times in the last 30 days.
AVLN (Avalyn Pharma Inc. Common Stock) trades on XNAS, with a market cap of about $1.40B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AVLN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AVLN discussion
Sign in to ask a question or join the discussion.